4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-032499
CIK 0000827871operating
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:28 PM ET
Size
5.8 KB
Accession
0001209191-17-032499
Insider Transaction Report
Form 4
Meyers Peter A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-05-15+50,000→ 50,000 totalExercise: $82.30Exp: 2027-05-14→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests over a period of four years, with 25% of the shares underlying the option vesting on May 15, 2018, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 7:28 PM ET
- Size
- 5.8 KB